COVID-19 vaccines
COVID-19 vaccines is a biological therapy with 14 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Genomics and COVID-19 Vaccine Adverse Events
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
National Project on Vaccines, COVID-19 and Frail Patients
Allergy and COVID-19 Vaccines
Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia
Clinical Trials (14)
Genomics and COVID-19 Vaccine Adverse Events
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
National Project on Vaccines, COVID-19 and Frail Patients
Allergy and COVID-19 Vaccines
Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.
Real-world Evidence of COVID-19 Vaccines Effectiveness
COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura
COVID-19 Vaccines in Patients With Chronic Liver Disease
Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina
COVID-19 Vaccine Effectiveness Among Health Workers in Georgia
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians
App-based Symptom Tracking After Corona Vaccination (CoCoV)
All 14 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 14